Cargando…

Characterization of human soft-tissue sarcoma xenografts for use in secondary drug screening.

We have established ten transplantable human soft-tissue sarcoma (STS) xenografts grown as subcutaneous tumours in the nude mouse. Nine xenografts originated from patients that needed chemotherapy in the course of their disease. The xenografts were tested for their sensitivity to maximum tolerated d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boven, E., Pinedo, H. M., van Hattum, A. H., Scheffer, P. G., Peters, W. H., Erkelens, C. A., Schlüper, H. M., Kuiper, C. M., van Ark-Otte, J., Giaccone, G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group\|1 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063242/ https://www.ncbi.nlm.nih.gov/pubmed/9862568

Ejemplares similares

Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice.
por: Nauta, M. M., et al.
Publicado: (1986)

CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein.
por: Jansen, W. J., et al.
Publicado: (1998)

Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity
por: van Hattum, A H, et al.
Publicado: (2002)

Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.
por: Kievit, E., et al.
Publicado: (1996)

The anti-tumour effects of the prodrugs N-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts.
por: Boven, E., et al.
Publicado: (1992)

The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts.
por: Houba, P. H., et al.
Publicado: (1998)

Determinants of CPT-11 and SN-38 activities in human lung cancer cells.
por: van Ark-Otte, J., et al.
Publicado: (1998)

Growth, morphology and chemosensitivity studies on postconfluent cells cultured in 'V'-bottomed microtiter plates.
por: Pizao, P. E., et al.
Publicado: (1992)

Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
por: Molthoff, C. F., et al.
Publicado: (1992)

Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.
por: Boven, E., et al.
Publicado: (1990)

The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer.
por: Boven, E., et al.
Publicado: (1993)

Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts
por: Kolfschoten, G M, et al.
Publicado: (2000)

Occurrence of Comorbidities before and after Soft Tissue Sarcoma Diagnosis
por: van Herk-Sukel, Myrthe P. P., et al.
Publicado: (2012)

DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents?
por: Smitskamp-Wilms, E., et al.
Publicado: (1995)

p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer.
por: Linn, S. C., et al.
Publicado: (1996)

A study of soft tissue sarcomas after childhood cancer in Britain
por: Jenkinson, H C, et al.
Publicado: (2007)

Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein.
por: Schuurhuis, G. J., et al.
Publicado: (1991)

Cortisol is transported by the multidrug resistance gene product P-glycoprotein.
por: van Kalken, C. K., et al.
Publicado: (1993)

Adherence to Guidelines for Adult (Non-GIST) Soft Tissue Sarcoma in the Netherlands: A Plea for Dedicated Sarcoma Centers
por: Hoekstra, Harald J., et al.
Publicado: (2017)

Management of Advanced Adult Soft Tissue Sarcoma
por: Bramwell, Vivien H. C.
Publicado: (2003)

Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell lines
por: Kroep, J R, et al.
Publicado: (2000)

Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats
por: Verschraagen, M, et al.
Publicado: (2004)

The semisynthetic flavonoid monoHER sensitises human soft tissue sarcoma cells to doxorubicin-induced apoptosis via inhibition of nuclear factor-κB
por: Jacobs, H, et al.
Publicado: (2011)

Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
por: Fischer, Suzanne, et al.
Publicado: (2023)

Sequential Dose-Dense Doxorubicin and Ifosfamide in Advanced Soft-Tissue Sarcoma Patients in an Out-Patient-Basis Schedule
por: Almeida, G. F. G., et al.
Publicado: (2011)

Soft Tissue Sarcoma: The Predominant Primary Malignancy in the Retroperitoneum
por: Dalen, Thijs van, et al.
Publicado: (2001)

Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts
por: Cornillie, Jasmien, et al.
Publicado: (2019)

Ecteinascidin-743: Evidence of Activity in Advanced, Pretreated Soft Tissue and Bone Sarcoma Patients
por: Huygh, G., et al.
Publicado: (2006)

Pazopanib in advanced soft tissue sarcomas
por: Lee, Alex T. J., et al.
Publicado: (2019)

Preoperative radiotherapy of soft-tissue sarcomas: surgical and radiologic parameters associated with local control and survival
por: Tsagozis, Panagiotis, et al.
Publicado: (2018)

Patient-derived xenografts for individualized care in advanced sarcoma
por: Stebbing, Justin, et al.
Publicado: (2014)

Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer.
por: Honkoop, A. H., et al.
Publicado: (1998)

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.
por: Nielsen, O. S., et al.
Publicado: (1998)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Enapotamab Vedotin, an AXL-Specific Antibody-Drug Conjugate, Demonstrates Antitumor Efficacy in Patient-Derived Xenograft Models of Soft Tissue Sarcoma
por: Van Renterghem, Britt, et al.
Publicado: (2022)

Accuracy of core needle biopsy for histologic diagnosis of soft tissue sarcoma
por: Kiefer, J., et al.
Publicado: (2022)

Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas
por: Chadha, Madhumeeta, et al.
Publicado: (2022)

Olaratumab’s failure in soft tissue sarcoma
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Childhood soft-tissue sarcoma associated with Sotos syndrome
por: Hill, Destin E., et al.
Publicado: (2015)

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines
por: Moorsel, C J A van, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_p4jmu6kga4bni11jq722p5pj6q